| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/AAC.11.4.656 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC352045 |
| https://europepmc.org/articles/PMC352045?pdf=render | ||
| https://journals.asm.org/doi/pdf/10.1128/AAC.11.4.656 | ||
| P932 | PMC publication ID | 352045 |
| P698 | PubMed publication ID | 193440 |
| P5875 | ResearchGate publication ID | 22944197 |
| P2093 | author name string | J. N. Dowling | |
| B. Postic | |||
| P2860 | cites work | Production of high-titered interferon in cultures of human diploid cells | Q24564415 |
| Experimental use of cytosine arabinoside in congenital cytomegalovirus infection | Q33463076 | ||
| Effect of adenine arabinoside on cytomegalovirus infections | Q34698715 | ||
| Cytomegalovirus infection in children undergoing open-heart surgery | Q36998400 | ||
| Semi-micro, dye-binding assay for rabbit interferon. | Q37169551 | ||
| The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. I. | Q39893759 | ||
| The Transplanted Kidney as a Source of Cytomegalovirus Infection | Q39958699 | ||
| Clinical Efficacy of Adenine Arabinoside in Therapy of Cytomegalovirus Infections in Renal Allograft Recipients | Q39968675 | ||
| Effect of Human Exogenous Leukocyte Interferon in Cytomegalovirus Infections | Q39996583 | ||
| Effect of Leukocyte Interferon on Urinary Excretion of Cytomegalovirus by Infants | Q39996590 | ||
| Cytomegalovirus Pneumonia After Human Marrow Transplantation | Q40307841 | ||
| Clinical aspects of cytomegalovirus infection in kidney-graft recipients | Q40907620 | ||
| Susceptibility of herpesviruses to three nucleoside analogues and their combinations and enhancement of the antiviral effect of acid pH. | Q44553729 | ||
| Inapparent congenital cytomegalovirus infection with elevated cord IgM levels. Casual relation with auditory and mental deficiency | Q44640742 | ||
| Two Variants of Sindbis Virus Which Differ in Interferon Induction and Serum Clearance. I. The Phenomenon | Q45809751 | ||
| Interferon and cytomegalovirus in vivo and in vitro | Q47966069 | ||
| Accentuation of production of human interferon by metabolic inhibitors | Q67269142 | ||
| Cytosine arabinoside in the treatment of congenital cytomegalic inclusion disease | Q68638086 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Cytomegalovirus | Q6946 |
| pharmacology | Q128406 | ||
| P304 | page(s) | 656-660 | |
| P577 | publication date | 1977-04-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Susceptibility of clinical isolates of cytomegalovirus to human interferon | |
| Susceptibility of Clinical Isolates of Cytomegalovirus to Human Interferon | |||
| P478 | volume | 11 |
| Q39509644 | Molecular biology and immunology of cytomegalovirus |
| Q37097273 | Prevention of Epstein-Barr virus-induced B-cell outgrowth by interferon alpha |
| Q72727033 | Rat cytomegalovirus: induction of and sensitivity to interferon |
| Q36589835 | Selective antiviral activity of human interferons on primate oncogenic and neurotropic herpesviruses |
| Q36467043 | Treatment of a Murine Cytomegalovirus Infection with Exogenous Interferon, Polyinosinic-Polycytidylic Acid, and Polyinosinic-Polycytidylic Acid–Poly- l -Lysine Complex |
Search more.